Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression

International Journal of Cancer

Volumn 127, Issue 12, 2010, Pages 2739-2748

  Sprenger, Cynthia C ^a   Plymate, Stephen R ^a,b   Reed, May J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Extracellular matrix; Matricellular proteins; Microenvironment; Prostate cancer; Senescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANDROGEN; COLLAGEN TYPE 1; HYALURONIC ACID; LAMININ; OSTEONECTIN; THROMBOSPONDIN 1;

AGING; ANGIOGENESIS; CANCER GROWTH; CELL INTERACTION; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RISK FACTOR; SENESCENCE; SHORT SURVEY; TUMOR MICROENVIRONMENT;

AGING; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HUMANS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 78249262940     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25615     Document Type: Short Survey

References (126)

1. Nadon NL,. Of mice and monkeys: national institute on aging resources supporting the use of animal models in biogerontology research. J Gerontol A Biol Sci Med Sci 2006; 61: 813 -5.
2. Dekker P, Maier AB, van Heemst D, de Koning-Treurniet C, Blom J, Dirks RW, Tanke HJ, Westendorp RG,. Stress-induced responses of human skin fibroblasts in vitro reflect human longevity. Aging Cell 2009; 8: 595 -603.
3. Herbig U, Ferreira M, Condel L, Carey D, Sedivy J,. Cellular senescence in aging primates. Science 2006; 311: 1257.
4. Hornsby P,. Cellular senescence and tissue aging in vivo. J Gerontol A Biol Sci Med Sci 2002; 57A: B125 -256.
5. Labat-Robert J, Robert L,. The effect of cell-matrix interactions and aging on the malignant process. Adv Cancer Res 2007; 98: 221 -59.
6. Nelson C, Bissell M,. Of extracellular matrix, scaffold, and signaling: tissue architecture regulates development, homeostasis, and cancer. Ann Rev Cell Dev Biol 2006; 22: 287 -309.
7. Campisi J,. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513 -22.
8. Bissell M, Radisky D,. Putting tumours in context. Nat Rev Cancer 2001; 1: 46 -54.
9. Tan T, Coussens L,. Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007; 19: 209 -16.
10. Kaplan R, Rafii S, Lyden D,. Preparing the soil: the premetastatic niche. Cancer Res 2006; 66: 11089 -93.
11. Langley R, Fidler I,. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007; 28: 297 -321.
12. Bierie B, Moses H,. Gain or loss of TGF-beta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 2009; 8: 3319 -27.
13. Giampieri S, Manning C, Hooper S, Jones L, Hill C, Sahai E,. Localized and reversible TGF-beta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009; 11: 1287 -96.
14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225 -49.
15. Zhang H, Pan K-H, Cohen S,. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc Natl Acad Sci USA 2003; 100: 3251 -6.
16. Bavik C, Coleman I, Dean J, Knudsen B, Plymate S, Nelson P,. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 2006; 66: 794 -802.
17. Coppe J-P, Patil C, Rodier F, Sun Y, Munoz D, Goldstein J, Nelson P, Desprez P-Y, Campisi J,. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: 2853 -68.
18. Liu D, Hornsby PJ,. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 2007; 67: 3117 -26.
19. Rodier F, Coppe J-P, Patil C, Hoeijmakers W, Munoz D, Raza S, Freund A, Campeau E, Davalos A, Campisi J,. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973 -9.
20. Sprenger C, Drivdahl R, Woodke L, Eyman D, Reed M, Carter W, Plymate S,. Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells. Neoplasia 2008; 10: 1350 -61.
21. Bissell M, Rizki A, Mian I,. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003; 15: 753 -62.
22. Gosselin K, Martien S, Pourtier A, Vercamer C, Ostoich P, Morat L, Sabatier L, Duprez L, T'Kint de Roodenbeke C, Gilson E, Malaquin N, Wernert N, et al. Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells. Cancer Res 2009; 69: 7917 -25.
23. Lawrenson K, Grun B, Benjamin E, Jacobs I, Dafou D, Gayther S,. Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia 2010; 12: 317 -25.
24. Liu D, Hornsby P,. Fibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect. Neoplasia 2007; 9: 418 -26.
25. Eyman D, Damodarasamy M, Plymate SR, Reed MJ,. CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis. J Cell Physiol 2009; 220: 376 -81.
26. Collado M, Serrano M,. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10: 51 -7.
27. Chang B-D, Broude E, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel E, Lausch E, Christov K, Roninson I,. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999; 59: 3761 -7.
28. Shay J, Roninson I,. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004; 23: 2919 -33.
29. Schmitt C,. Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nat Rev Cancer 2003; 3: 285 -95.
30. Schwarze S, Fu V, Desotelle J, Kenowski M, Jarrard D,. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 2005; 7: 816 -23.
31. Xue W, Zender L, Meithing C, Dickins R, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe S,. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656 -60.
32. Majumder P, Grisanzio C, O'Connell F, Barry M, Brito J, Xu Q, Guney I, Berger R, Herman P, Bikoff R, Fedele G, Baek W-K, et al. A prostatic intraepithelial neoplasia-dependent p27Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. Cancer Cell 2008; 14: 146 -55.
33. Ershler W,. Why tumors grow more slowly in old people. J Natl Cancer Inst 1986; 77: 837 -9.
34. Kreisle R, Stebler B, Ershler W,. Effect of host age on tumor-associated angiogenesis in mice. J Natl Cancer Inst 1990; 82: 44 -7.
35. Pili R, Guo Y, Chang J, Nakanishi H, Martin G, Passaniti A,. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 1994; 86: 1303 -14.
36. Itzhaki O, Skutelsky E, Kaptzan T, Siegal A, Sinai J, Schiby G, Michowitz M, Huszar M, Leibovici J,. Decreased DNA ploidy may constitute a mechanism of the reduced malignant behavior of B16 melanoma in aged mice. Exp Gerontol 2008; 43: 164 -75.
37. Kaptzan T, Skutelsky E, Itzhaki O, Sinai J, Michowitz M, Yossipov Y, Schiby G, Leibovici J,. Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains. Exp Gerontol 2004; 39: 1035 -48.
38. Gronberg H, Damber JE, Jonsson H, Lenner P,. Patient age as a prognostic factor in prostate cancer. J Urol 1994; 152: 892 -5.
39. Reed M, Karres N, Eyman D, Cruz A, Brekken R, Plymate S,. The effects of aging on tumor growth and angiogenesis are tumor-cell dependent. Int J Cancer 2007; 120: 753 -60.
40. Chung L, Baseman A, Assikis V, Zhau H,. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 2005; 173: 10 -20.
41. Shuster S, Black MM, McVitie E,. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 93: 639 -43.
42. Heino J,. The collagen family members as cell adhesion proteins. Bioessays 2007; 29: 1001 -10.
43. Gordon M, Hahn R,. Collagens. Cell Tissue Res 2010; 339: 247 -57.
44. Ashcroft G, Dodsworth J, van Boxtel E, Tarnuzzer R, Horan M, Schultz G, Ferguson M,. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat Med 1997; 3: 1209 -15.
45. Hornebeck W, Emonard H, Monboisee J-C, Bellon G,. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 2002; 12: 231 -41.
46. Gazoti Debessa C, Mesiano Maifrino L, Rodrigues de Souza R,. Age related changes of the collagen network of the human heart. Mech Ageing Dev 2001; 122: 1049 -58.
47. Lakatta EG,. Arterial aging is risky. J Appl Physiol 2008; 105: 1321 -2.
48. Fisher GJ, Varani J, Voorhees JJ,. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol 2008; 144: 666 -72.
49. Reed M, Ferara N, Vernon R,. Impaired migration, integrin function, and actin cytoskeletal organization in dermal fibroblasts from a subset of aged human donors. Mech Ageing Dev 2001; 122: 1203 -20.
50. Gorlov IP, Byun J, Gorlova OY, Aparicio AM, Efstathiou E, Logothetis CJ,. Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data. BMC Med Genomics 2009; 2: 48.
51. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139: 891 -906.
52. Gehler S, Baldassarre M, Lad Y, Leight J, Wozniak M, Riching K, Eliceiri K, Weaver V, Calderwood D, Keely P,. Filamin A-beta 1 integrin complex tunes epithelial cell response to matrix tension. Mol Biol Cell 2009; 20: 3224 -38.
53. Rivard A, Fabre J, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner J,. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111 -20.
54. Sadoun E, Reed M,. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J Hist Cytochem 2003; 51: 1119 -30.
55. Bartling B, Desole M, Rohrbach S, Silber R-E, Simm A,. Age-associated changes of extracellular matrix collagen impair lung cancer cell migration. FASEB J 2009; 23: 1510 -20.
56. Damodarasamy M, Vernon RB, Karres N, Chang CH, Bianchi-Frias D, Nelson PS, Reed MJ,. Collagen extracts derived from young and aged mice demonstrate different structural properties and cellular effects in three-dimensional gels. J Geront:Biol Sci 2010; 65: 209 -18.
57. Bianchi-Frias D, Vakar-Lopez F, Coleman I, Reed M, Plymate S, Nelson P,. The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS One 2010;5:pii: e12501.
58. Patarroyo M, Tryggvason K, Virtanen I,. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 2002; 12: 197 -207.
59. Brar P, Dalkin B, Weyer C, Sallam K, Virtanen I, Nagle R,. Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubetal benign prostate glands and adult benign and malignant prostate glands. Prostate 2003; 55: 65 -70.
60. Nagle R,. Role of the extracellular matrix in prostate carcinogenesis. J Cell Biochem 2004; 91: 36 -40.
61. Brawer M,. Prostatic intraepithelial neoplasia: an overview. Rev Urol 2005; 7: S11 -8.
62. Hao J, Yang Y, McDaniel K, Dalkin B, Cress A, Nagle R,. Differential expression of Laminin 5 (α3β3-2) by human malignant and normal prostate. Am J Pathol 1996; 149: 1341 -9.
63. Udayakumar T, Chen M, Bair E, von Bredow D, Cress A, Nagle R, Bowden G,. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 β3 chain and induces cell migration. Cancer Res 2003; 63: 2292 -9.
64. Tripathi M, Nandana S, Yamashita H, Ganesan R, Kirchhofer D, Quaranta V,. Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J Biol Chem 2008; 283: 30576 -84.
65. Calaluce R, Kunkel M, Watts G, Schmelz M, Hao J, Barrera J, Gleason-Guzman M, Isett R, Fitchmun M, Bowden G, Cress A, Futscher B, et al. Laminin-5-mediated gene expression in human prostate carcinoma cells. Mol Carcinog 2001; 30: 119 -29.
66. Luo J, Dunn T, Ewing C, Sauvageot J, Chen Y, Trent J, Isaacs W,. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 2002; 51: 189 -200.
67. Zhou Z, Doi M, Wang J, Cao R, Liu B, Chan K, Kortesmaa J, Sorokin L, Cao Y, Tryggvason K,. Deletion of laminin-8 results in increased tumor neovascularization and metastasis in mice. Cancer Res 2004; 64: 4059 -63.
68. Wu C, Ivars F, Anderson P, Hallmann R, Vestweber D, Nilsson P, Robenek H, Tryggvason K, Song J, Korpos E, Loser K, Beissert S, et al. Endothelial basement membrane laminin alpha 5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med 2009; 15: 519 -27.
69. Elola M, Wolfenstein-Todel C, Troncoso M, Vasta G, Rabinovich G,. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 2007; 64: 1679 -700.
70. Naumov G, Bender E, Zurakowski D, Kang S, Sampson D, Flynn E, Watnick R, Straume O, Akslen L, Folkman J, Almog N,. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 2006; 98: 316 -25.
71. Zaslavsky A, Baek KH, Lynch RC, Short S, Grillo J, Folkman J, Italiano JE, Jr, Ryeom S,. Platelet-derived thrombospondin-1 (TSP-1) is a critical negative regulator and potential biomarker of angiogenesis. Blood 2010; 115: 4605 -13.
72. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001; 37: 601 -11.
73. Agah A, Kyriakides TR, Letrondo N, Bjorkblom B, Bornstein P,. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix Biol 2004; 22: 539 -47.
74. Isenberg JS, Hyodo F, Pappan LK, Abu-Asab M, Tsokos M, Krishna MC, Frazier WA, Roberts DD,. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia. Arterioscler Thromb Vasc Biol 2007; 27: 2582 -8.
75. Colombel M, Filleur S, Fournier P, Merle C, Guglielmi J, Courtin A, Degeorges A, Serre C, Bouvier R, Clezardin P, Cabon F,. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Cancer Res 2005; 65: 300 -8.
76. John AS, Hu X, Rothman VL, Tuszynski GP,. Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion. Exp Mol Pathol 2009; 87: 184 -8.
77. Solomon KR, Pelton K, Boucher K, Joo J, Tully C, Zurakowski D, Schaffner CP, Kim J, Freeman MR,. Ezetimibe is an inhibitor of tumor angiogenesis. Am J Pathol 2009; 174: 1017 -26.
78. Goel H, Moro L, Murphy-Ullrich J, Hsieh C-C, Wu C-L, Jiang Z, Languino L,. Beta 1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1. Cancer Res 2009; 69: 5374 -82.
79. Fontana A, Filleur S, Guglielmi J, Frappart L, Bruno-Bossio G, Boissier S, Cabon F, Clezardin P,. Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int J Cancer 2005; 116: 689 -91.
80. Sage E, Clark C,. A prototypic matricellular protein in the tumor microenvironment-where there's SPARC, there's fire. J Cell Biochem 2008; 104: 721 -32.
81. Giudici C, Raynal N, Wiedemann H, Cabral WA, Marini JC, Timpl R, Bachinger HP, Farndale RW, Sasaki T, Tenni R,. Mapping of SPARC/BM-40/ osteonectin-binding sites on fibrillar collagens. J Biol Chem 2008; 283: 19551 -60.
82. Hohenester E, Sasaki T, Giudici C, Farndale RW, Bachinger HP,. Structural basis of sequence-specific collagen recognition by SPARC. Proc Natl Acad Sci USA 2008; 105: 18273 -7.
83. Bradshaw AD, Baicu CF, Rentz TJ, Van Laer AO, Bonnema DD, Zile MR,. Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing. Am J Physiol Heart Circ Physiol 2010; 298: H614 -22.
84. Thomas R, True L, Bassuk J, Lange P, Vessella R,. Differential expression of osteonectin/SPARC during human prostate cancer progression. Clin Cancer Res 2000; 6: 1140 -9.
85. Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, Olive MB, Sloane BF,. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol 2009; 175: 1255 -69.
86. Kupprion C, Motamed K, Sage EH,. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 1998; 273: 29635 -40.
87. Sage EH, Reed MJ, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH, Bassuk JA,. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem 2003; 278: 37849 -57.
88. Arnold S, Brekken R,. SPARC: a matricelluar regulator of tumorigenesis. J Cell Commun Signal 2009; 3: 255 -73.
89. Reed MJ, Bradshaw A, Shaw M, Sadoun E, Han N, Ferara N, Funk SE, Puolakkainen P, Sage EH,. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age. J Cell Physiol 2005; 204: 800 -7.
90. Clark CJ, Sage EH,. A prototypic matricellular protein in the tumor microenvironment-where there's SPARC, there's fire. J Cell Biochem 2008; 104: 721 -32.
91. Wong SY, Crowley D, Bronson RT, Hynes RO,. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer. Clin Exp Metastasis 2008; 25: 109 -18.
92. Said N, Frierson H, Chernauskas D, Conaway M, Motamed K, Theodorescu D,. The role of SPARC in the TRAMP model of prostate carcinogenesis and progression. Oncogene 2009; 28: 3487 -98.
93. Bull Phelps S, Carbon J, Miller A, Castro-Rivera E, Arnold S, Brekken R, Lea J,. Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity. Am J Obstet Gynecol 2009; 200: 180.e1 -7.
94. Toole BP,. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528 -39.
95. Simpson MA, Reiland J, Burger SR, Furcht LT, Spicer AP, Oegema TR, Jr, McCarthy JB,. Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J Biol Chem 2001; 276: 17949 -57.
96. Simpson MA, Wilson CM, McCarthy JB,. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol 2002; 161: 849 -57.
97. Simpson RM, Meran S, Thomas D, Stephens P, Bowen T, Steadman R, Phillips A,. Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation. Am J Pathol 2009; 175: 1915 -28.
98. Meyer LJ, Stern R,. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol 1994; 102: 385 -9.
99. Ghersetich I, Lotti T, Campanile G, Grappone C, Dini G,. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol 1994; 33: 119 -22.
100. Robert L, Robert AM, Renard G,. Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging. Pathol Biol (Paris) 2009; 58: 187 -98.
101. Lipponen P, Aaltomaa S, Tammi R, Tammi M, Agren U, Kosma VM,. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer 2001; 37: 849 -56.
102. Gomez CS, Gomez P, Knapp J, Jorda M, Soloway MS, Lokeshwar VB,. Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence. J Urol 2009; 182: 1350 -6.
103. Bharadwaj A, Kovar J, Loughman E, Elowsky C, Oakley G, Simpson M,. Spontaneous metastatis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol 2009; 174: 1027 -36.
104. Weigel PH, Hascall VC, Tammi M,. Hyaluronon synthases. J Biol Chem 1997; 272: 13997 -4000.
105. Harris EN, Kyosseva SV, Weigel JA, Weigel PH,. Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE). J Biol Chem 2007; 282: 2785 -97.
106. Stern R,. Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol 2005; 53: 372 -82.
107. Liu N, Gao F, Han Z, Xu X, Underhill CB, Zhang L,. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 2001; 61: 5207 -14.
108. Kosaki R, Watanabe K, Yamaguchi Y,. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Res 1999; 59: 1141 -5.
109. Hayen W, Goebeler M, Kumar S, Riessen R, Nehls V,. Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci 1999; 112 (Part 13): 2241 -51.
110. Annabi B, Thibeault S, Moumdjian R, Beliveau R,. Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells. J Biol Chem 2004; 279: 21888 -96.
111. Ricciardelli C, Russell DL, Ween MP, Mayne K, Suwiwat S, Byers S, Marshall VR, Tilley WD, Horsfall DJ,. Formation of hyaluronan-and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem 2007; 282: 10814 -25.
112. Subramaniam V, Gardner H, Jothy S,. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells. Exp Mol Pathol 2007; 83: 341 -6.
113. Handorean AM, Yang K, Robbins EW, Flaig TW, Iczkowski KA,. Silibinin suppresses CD44 expression in prostate cancer cells. Am J Transl Res 2009; 1: 80 -6.
114. Yang K, Tang Y, Habermehl GK, Iczkowski KA,. Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity. BMC Cancer 2010; 10: 16.
115. Ghatak S, Misra S, Toole BP,. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem 2005; 280: 8875 -83.
116. West DC, Hampson IN, Arnold F, Kumar S,. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985; 228: 1324 -6.
117. West DC, Kumar S,. Hyaluronan and angiogenesis. Ciba Found Symp 1989; 143: 187 -201; discussion -7, 81-5.
118. Rahmanian M, Pertoft H, Kanda S, Christofferson R, Claesson-Welsh L, Heldin P,. Hyaluronan oligosaccharides induce tube formation of a brain endothelial cell line in vitro. Exp Cell Res 1997; 237: 223 -30.
119. Montesano R, Kumar S, Orci L, Pepper MS,. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest 1996; 75: 249 -62.
120. Liu D, Pearlman E, Diaconu E, Guo K, Mori H, Haqqi T, Markowitz S, Willson J, Sy MS,. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci USA 1996; 93: 7832 -7.
121. Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA,. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 2005; 98: 193 -202.
122. Kovar JL, Johnson MA, Volcheck WM, Chen J, Simpson MA,. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 2006; 169: 1415 -26.
123. Stern R,. Hyaluronidases in cancer biology. Semin Cancer Biol 2008; 18: 275 -80.
124. Lokeshwar VB, Cerwinka WH, Isoyama T, Lokeshwar BL,. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Res 2005; 65: 7782 -9.
125. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M, Lokeshwar BL,. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 2001; 276: 11922 -32.
126. Miyamoto I, Nagase S,. Age-related changes in the molecular weight of hyaluronic acid from rat skin. Jikken Dobutsu 1984; 33: 481 -5.